| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |